2 Under-the-Radar Pharma M&A Targets for 2018 Post author:Sam Post published:January 10, 2018 Post category:BioPharma A look at why these two biopharma companies could have targets on their backs. Source: BioSpace You Might Also Like Tesaro Announces Niraparib Data Presentations At The 2017 Annual Meeting On Women's Cancer March 12, 2017 CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation September 26, 2017 Silicon Valley VCs Quietly Hiring Biotech Experts May 23, 2017
Tesaro Announces Niraparib Data Presentations At The 2017 Annual Meeting On Women's Cancer March 12, 2017
CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation September 26, 2017
